đ Highwoods Properties Downgraded, Salesforce Upgraded, Extra Space Storage Upgraded and moreâŠ
RJ Hamster
Advertisements
Ratings changes for Micron Technology, Micron Technology, Amazon.com, Cipher Mining, vTv Therapeutics, Adaptimmune Therapeutics, argenx and moreâŠUpgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.
VIEW MY PORTFOLIO
December 21st, 2023
 Â
The A.I. Trend Has These 7 Stocks Set To Soar (ad)
Making profits in the stock market depends on making your entry at the right time. The time is NOW to get into A.I. Artificial Intelligence is turning into one of the most popular trends this year, and it has only just begun.
(**By clicking the link you are subscribing to the The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
Best way to buy gold today (not what youâd think) (ad)
With so many strange events happening across the economy (longest bear market for bonds since Civil War⊠unprecedented bank closures⊠and soaring prices) â itâs no wonder the richest investors are loading up on gold. But what you might not realize is thereâs a much better way to profit from rising gold prices â without ever touching an ETF, mining stock, or even bullion.
Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at Wedbush (Â Â Â Â ) from $180.00 to $210.00. They now have an âoutperformâ rating on the stock. This represents a 37.1% upside from the current price of $153.13.
Alphabet saw some unusual options trading on Wednesday. Stock investors bought 329,748 call options on the stock. This is an increase of 20% compared to the average volume of 275,131 call options.
CEO Mark Zuckerberg sold 46,509 shares of the companyâs stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $352.05, for a total value of $16,373,493.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
CEO Mark Zuckerberg sold 28,009 shares of the firmâs stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $344.12, for a total transaction of $9,638,457.08. The transaction was disclosed in a filing with the SEC, which is available at this link.
Amgen (NASDAQ:AMGN) was upgraded by analysts at Daiwa Capital Markets from a âneutralâ rating to a âbuyâ rating. They now have a $320.00 price target on the stock, up previously from $264.00. This represents a 14.6% upside from the current price of $279.14.
Annexon (NASDAQ:ANNX) was upgraded by analysts at Bank of America Co. from a âneutralâ rating to a âbuyâ rating. They now have a $6.00 price target on the stock, up previously from $4.00. This represents a 76.0% upside from the current price of $3.41.
Cheesecake Factory (NASDAQ:CAKE) was upgraded by analysts at Wedbush from a âneutralâ rating to an âoutperformâ rating. They now have a $40.00 price target on the stock, up previously from $34.00. This represents a 13.7% upside from the current price of $35.17.
CAVA Group (NYSE:CAVA) was upgraded by analysts at Wedbush from a âneutralâ rating to an âoutperformâ rating. They now have a $48.00 price target on the stock, up previously from $35.00. This represents a 14.5% upside from the current price of $41.92.
Salesforce (NYSE:CRM) was upgraded by analysts at Morgan Stanley from an âequal weightâ rating to an âoverweightâ rating. They now have a $350.00 price target on the stock, up previously from $290.00. This represents a 32.0% upside from the current price of $265.20.
Extra Space Storage (NYSE:EXR) was upgraded by analysts at Morgan Stanley from an âunderweightâ rating to an âequal weightâ rating. They now have a $150.00 price target on the stock, up previously from $115.00. This represents a 3.4% downside from the current price of $155.29.
JFrog (NASDAQ:FROG) was upgraded by analysts at Morgan Stanley from an âequal weightâ rating to an âoverweightâ rating. They now have a $42.00 price target on the stock, up previously from $32.00. This represents a 22.1% upside from the current price of $34.40.
Glaukos (NYSE:GKOS) was upgraded by analysts at JPMorgan Chase & Co. from a âneutralâ rating to an âoverweightâ rating. They now have a $91.00 price target on the stock, up previously from $66.00. This represents a 7.8% upside from the current price of $84.44.
Merit Medical Systems (NASDAQ:MMSI) was upgraded by analysts at Canaccord Genuity Group Inc. from a âholdâ rating to a âbuyâ rating. They now have a $100.00 price target on the stock. This represents a 35.8% upside from the current price of $73.63.
Merit Medical Systems (NASDAQ:MMSI) was upgraded by analysts at Canaccord Genuity Group Inc. from a âholdâ rating to a âbuyâ rating. They now have a $100.00 price target on the stock, up previously from $76.00. This represents a 35.8% upside from the current price of $73.63.
Insulet (NASDAQ:PODD) was upgraded by analysts at Robert W. Baird from a âneutralâ rating to an âoutperformâ rating. They now have a $238.00 price target on the stock, up previously from $180.00. This represents a 10.4% upside from the current price of $215.63.
Regency Centers (NASDAQ:REG) was upgraded by analysts at Morgan Stanley from an âequal weightâ rating to an âoverweightâ rating. They now have a $75.00 price target on the stock, up previously from $62.00. This represents a 13.6% upside from the current price of $66.05.
Spotify Technology (NYSE:SPOT) was upgraded by analysts at Pivotal Research from a âholdâ rating to a âbuyâ rating. They now have a $265.00 price target on the stock, up previously from $170.00. This represents a 36.8% upside from the current price of $193.74.
Urban Edge Properties (NYSE:UE) was upgraded by analysts at Morgan Stanley from an âunderweightâ rating to an âequal weightâ rating. They now have a $18.00 price target on the stock, up previously from $14.00. This represents a 2.7% downside from the current price of $18.49.
The #1 Best Thing You Can Do Before New Year To Thrive In The Next Decade (ad)
What if you could do just one thing today and know that your bills and expenses will be taken care of over the next 10 years? Itâs possible. A group of over 20,000 has done it already. And now, itâs your chance to repeat their success â with just 3 stocks.
Chipotle Mexican Grill (NYSE:CMG) was downgraded by analysts at Wedbush from an âoutperformâ rating to a âneutralâ rating. They now have a $2,400.00 price target on the stock. This represents a 4.0% upside from the current price of $2,307.25.
Highwoods Properties (NYSE:HIW) was downgraded by analysts at Morgan Stanley from an âequal weightâ rating to an âunderweightâ rating. They now have a $18.00 price target on the stock, down previously from $22.00. This represents a 20.7% downside from the current price of $22.71.
Nevro (NYSE:NVRO) was downgraded by analysts at Canaccord Genuity Group Inc. from a âbuyâ rating to a âholdâ rating. They now have a $23.00 price target on the stock. This represents a 10.0% upside from the current price of $20.91.
Simon Property Group (NYSE:SPG) was downgraded by analysts at Morgan Stanley from an âoverweightâ rating to an âequal weightâ rating. They now have a $143.00 price target on the stock, up previously from $132.00. This represents a 0.4% upside from the current price of $142.36.
Wendyâs (NASDAQ:WEN) was downgraded by analysts at Wedbush from an âoutperformâ rating to a âneutralâ rating. They now have a $21.00 price target on the stock. This represents a 6.9% upside from the current price of $19.64.
How to Make Up to $700k in Dividends Over the Next 10 Years With Just 3 Stocks (ad)
In 2014, one Dividend Master recommended three under-the-radar stocks to a small group of retirees. Almost a decade later, these picks have generated $671,727 in an average IRA. Now, heâs repeating this all over with another 3 stocks to hold for the next ten years.
Envoy Medical (NASDAQ:COCH) is now covered by analysts at Northland Securities. They set an âoutperformâ rating on the stock.The current price is $2.37.
Catalyst Pharmaceuticals (NASDAQ:CPRX) is now covered by analysts at Oppenheimer Holdings Inc.. They set an âoutperformâ rating and a $30.00 price target on the stock. This represents a 85.3% upside from the current price of $16.19.
Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at Jefferies Financial Group Inc.. They set a âholdâ rating and a $35.00 price target on the stock. This represents a 1.1% upside from the current price of $34.63.
Genius Sports (NYSE:GENI) is now covered by analysts at Macquarie. They set an âoutperformâ rating and a $11.00 price target on the stock. This represents a 78.6% upside from the current price of $6.16.
J.Jill (NYSE:JILL) is now covered by analysts at William Blair. They set an âoutperformâ rating on the stock.The current price is $26.00.
Myriad Genetics (NASDAQ:MYGN) is now covered by analysts at Piper Sandler. They set a âneutralâ rating and a $23.00 price target on the stock. This represents a 13.2% upside from the current price of $20.32.
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at BTIG Research. They set a âbuyâ rating and a $11.00 price target on the stock. This represents a 221.6% upside from the current price of $3.42.
Rollins (NYSE:ROL) is now covered by analysts at Morgan Stanley. They set an âequal weightâ rating and a $42.00 price target on the stock. This represents a 1.5% downside from the current price of $42.63.
Sign up for MarketBeat All Access to gain access to MarketBeatâs full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatâs trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatâs happening in the market right now with MarketBeatâs real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeatâs free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (thatâs you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
